医学
星状神经节
麻醉
硬膜外阻滞
病理
替代医学
作者
Veronica Dusi,Filippo Angelini,Enrico Baldi,Antonio Toscano,Carol Gravinese,Simone Frea,Sara Compagnoni,Anna Rita Morena,Andrea Saglietto,Eleonora Balzani,Matteo Giunta,Andrea Costamagna,Stefano Salizzoni,Anna Chiara Trompeo,Roberto Rordorf,Matteo Anselmino,Simone Savastano,Gaetano M. De Ferrari
出处
期刊:Europace
[Oxford University Press]
日期:2024-03-26
标识
DOI:10.1093/europace/euae074
摘要
Abstract Background Percutaneous stellate ganglion block (PSGB) through single bolus injection and thoracic epidural anaesthesia (TEA) have been proposed for the acute management of refractory ventricular arrhythmias (VAs). However, data on continuous PSGB (C-PSGB) are scant. Aims To report our dual-center experience with C-PSGB and to perform a systematic review on C-PSGB and TEA. Methods Consecutive patients receiving C-PSGB at 2 centers were enrolled. The systematic literature review follows the latest PRISMA criteria. Results Our case series (26 patients, 88% male, 60±16 years, all with advanced structural heart disease, LVEF 23±11%, 32 C-PSGB performed, median duration 3 days) shows that C-PSGB is feasible and safe and leads to complete VAs suppression in 59% and to overall clinical benefit in 94% of cases. Overall, 61 patients received 68 C-PSGB and 22 TEA, with complete VAs suppression in 63% of C-PSGBs (61% of patients). Most TEA procedures (55%) were performed on intubated patients, as opposed to 28% C-PSGBs (p=0.02); 52% of patients were on full anticoagulation at C-PSGB, none at TEA (p<0.001). Ropivacaine and lidocaine were the most used drugs for C-PSGB, and the available data support a starting dose of 12 mg/h and 100 mg/h, respectively. No major complications occurred, yet TEA discontinuation rate due to side-effects was higher than C-PSGB (18% versus 1%, p=0.01). Conclusions C-PSGB seems feasible, safe, and effective for the acute management of refractory VAs. The antiarrhythmic effect may be accomplished with less concerns for concomitant anticoagulation compared to TEA, and with a lower side-effects related discontinuation rate.
科研通智能强力驱动
Strongly Powered by AbleSci AI